SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is trending as investors are weighing the impact of Gravity SUV deliveries and new partnerships against concerns about potential dilution and the company's ability to meet production targets. Community discussions revolve around the company's long-term viability, particularly its cash burn rate and the effectiveness of recent marketing efforts. Sentiment is mixed, with some bulls touting the quality of Lucid's vehicles, while bears point to the company's financial challenges and competitive pressures within the EV sector.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency <1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

Hype Crypto is trending due to increased volume and renewed attention, particularly around its DEX and L1 ecosystem. The community is actively discussing potential breakout ranges and points to its potential as the 'house of all finance,' with some suggesting it could rival major platforms. Recent news of an AI bot launch and quantum-resistant infrastructure may also be driving interest.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance ($PSKY) is trending as discussions around a potential acquisition of Warner Bros. Discovery ($WBD) heat up, with reports suggesting a $60 billion bid involving private equity firms. Community members are debating the merits of the deal, potential regulatory hurdles, and whether CEO David Ellison can successfully navigate the complexities of a major media merger, while some express concern about overpaying for WBD and its debt.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

Plasma ($XPL) is trending amid discussions about its listing on a Chinese exchange and the broader implications of stablecoin developments, including a Federal Reserve conference on the topic. Community members are weighing the potential impact of these events, with some pointing to its underlying technology and others expressing caution due to recent price volatility. There is also discussion around potential connections to other projects and exchanges.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

VIR is trending due to positive clinical trial data for its hepatitis delta treatment and the announcement of an upcoming Phase 3 registrational program, sparking optimism about its potential to address a rare and life-threatening condition. Community discussions revolve around the company's promising pipeline, strong cash position, and potential partnerships, particularly with GlaxoSmithKline, as well as recent insider activity and analyst ratings. Some investors also express concerns about dilution and the timing of data releases.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

Biogen (BIIB) is trending due to a flurry of activity surrounding its pipeline and potential strategic moves, including a confirmed unsolicited acquisition proposal for Sage Therapeutics (SAGE). While some analysts express concerns about revenue and future growth, the community is discussing the potential for undervaluation and a turnaround, particularly with advancements in Alzheimer's treatments and new drug launches offsetting multiple sclerosis portfolio challenges. Chatter also highlights a C5aR license agreement and its potential read-through to InflaRx.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors discuss the recent pullback and potential for a rebound. Community members are pointing to upcoming earnings and broader sector trends, along with potential deregulation, as possible catalysts while closely monitoring insider activity and institutional investment.

Ball Corp. engages in the supplies of aluminum packaging for the beverage, personal care, and household products industries. It operates through the following segments: Beverage Packaging North and Central America, Beverage Packaging South America, and Beverage Packaging Europe, Middle East and Africa (EMEA). The Beverage Packaging North and Central America segment includes multi-year supply contracts to fillers of carbonated soft drinks, beer, energy drinks, and other beverages. The Beverage Packaging South America segment includes beverage containers in South America, and the manufacture of substantially all the metal beverage containers in Brazil. The Beverage Packaging EMEA segment consists of metal beverage containers in Europe, and other packaging materials used by the European beer and carbonated soft drink industries. The company was founded by Edmund Burke Ball, Frank Clayton Ball, George A. Ball, Lucius Lorenzo Ball, and William Charles Ball in 1880 and is headquartered in Westminster, CO.

Ball Corp.

Recent analyst rating adjustments and price target reductions have spurred discussion around $BALL. The community is also closely monitoring the completed sale of Ball's Russian beverage packaging business and its impact on the company's financials. Additionally, new partnerships are being weighed against concerns about aluminum costs and demand changes.

Unum Group engages in the provision of financial protection benefits. Its services include disability, life, accident, critical illness, dental, vision, and other related services. It operates through the following segments: Unum US, Unum International, Colonial Life, Closed Block, and Corporate. The Unum US segment focuses on group disability, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business. The Unum International segment engages in the operations of the UK business, which includes insurance for group long-term disability, group life, and supplemental lines of business that include dental, individual disability, and critical illness products. The Colonial Life segment includes insurance for accident, sickness, disability products, life products, and cancer and critical illness products. The Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. The Corporate segment refers to investment income on corporate assets and other corporate income and expenses not allocated to a line of business. The company was founded in 1848 and is headquartered in Chattanooga, TN.

Unum Group

Unum Group ($UNM) is trending due to recent analyst rating updates and target price increases, reflecting optimism about the company's financial outlook. The community is actively discussing potential breakout patterns and the stock's performance relative to the broader market. Positive analyst sentiment is driving interest in UNM, which operates within the insurance sector.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto ($CLANKER) is trending due to its recent activity and small circulating supply, leading to volatile spikes. The community is closely watching for potential Coinbase integration and how that might affect the token's price. Some users also mention its potential within the AI space and the broader Base App ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific

NVIDIA, Roche, and Lam Research lead this week's top Zacks research picks, while Tredegar and Kewaunee Scientific highlight strong niche and microcap opportunities.

Top Stock Reports for NVIDIA, Roche & Lam Research

NVIDIA, Roche, and Lam Research lead today's top Zacks reports, showcasing standout growth drivers and sector-specific strengths.

Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%

KEQU's Q1 revenues and EPS grow y/y, aided by Nu Aire, yet shares drop 19% as investors weigh uneven project timelines and rising costs.

The Zacks Analyst Blog Highlights Lowe's, Bristol-Myers Squibb, Marvell Technology and Kewaunee Scientific

Zacks spotlights Lowe's, Bristol Myers, Marvell, and Kewaunee Scientific as earnings, strategy, and acquisitions shape growth outlooks.

Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology

Lowe's leans on Pro-focused strategy and AI-powered retail tools, Bristol-Myers banks on new drug launches to offset legacy declines, and Marvell rides AI-driven data center growth despite consumer softness.

Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog

KEQU earns an upgrade to "Outperform" as Nu Aire integration drives sales growth, margins expand and a record backlog boosts visibility, offsetting tariff risks with proactive inventory strategies.

The Zacks Analyst Blog Highlights NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific and Natural Health Trends

NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific, and Natural Health Trends show strong market momentum, each leveraging unique growth drivers despite sector-specific challenges.

Top Research Reports for NVIDIA, Palantir & Coca-Cola

PLTR's soaring stock, AI momentum, and S&P 500 inclusion make it a standout in today's top research reports.

Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates

KEQU posts strong Q4 and FY25 results, driving a 47% stock surge as sales jump and the Nu Aire acquisition boosts growth momentum.

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 PR Newswire STATESVILLE, N.C., Dec. 11, 2024...

Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. It operates through the following segments: Domestic, International, and Corporate. The Domestic segment designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International segment offers products and services, including facility design, engineering, construction, and project management from the planning stage through testing and commissioning of laboratories. The company was founded in 1906 and is headquartered in Statesville, NC.

Kewaunee Scientific Corporation

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

KEQU
Kewaunee Scientific Corporation

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest KEQU News

KEQUKewaunee Scientific Corporation